Interpreting the RAPIDO trial: factors to consider
Lancet Oncol
.
2021 Mar;22(3):e89.
doi: 10.1016/S1470-2045(21)00072-3.
Authors
Alessandro Pastorino
1
,
Maria Emanuela Negru
2
,
Carlo Aschele
2
Affiliations
1
Medical Oncology Unit, Department of Oncology, Ospedale Sant'Andrea, La Spezia 19121, Italy. Electronic address:
[email protected]
.
2
Medical Oncology Unit, Department of Oncology, Ospedale Sant'Andrea, La Spezia 19121, Italy.
PMID:
33662296
DOI:
10.1016/S1470-2045(21)00072-3
No abstract available
Publication types
Letter
Comment
MeSH terms
Chemoradiotherapy
Chemotherapy, Adjuvant
Humans
Rectal Neoplasms*
Rectum